News

Looking Forward: M/I Homes Earnings Insights and Predictions

Looking Forward: M/I Homes Earnings Insights and Predictions

M/I Homes Prepares for Quarterly Earnings Announcement

M/I Homes (MHO) is gearing up to unveil its quarterly earnings report soon. Investors are eagerly awaiting this announcement, as it could provide crucial insights into the company's future performance and its trajectory in the housing market.

Expected Earnings Performance

Analysts are forecasting M/I Homes to deliver an earnings per share (EPS) of $4.43. This figure plays a vital role in shaping investor expectations, especially when it comes to trends in the home building sector.

Understanding Past Earnings Results

In the last earnings announcement, there was a notable discrepancy, as the company missed its EPS target by $0.18. Interestingly, this hiccup still resulted in a share price increase of 1.74% the following day, showing how market reactions can diverge from expectations based on broader sentiments.

Past Performance Overview

An overview of M/I Homes’ recent earnings history highlights the company’s fluctuating performance:

EPS Estimate: The following estimates were recorded: $4.16 for Q1 2025, $4.83 for Q4 2024, $4.94 for Q3 2024, and $4.59 for Q2 2024.

EPS Actual: In contrast, the actual EPS reported was $3.98 for Q1 2025, and other quarterly performances varied between $4.71 and $5.12 across quarters mentioned.

Price Change %: The corresponding changes in share price were observed as 2.0% for Q1 2025, 1.0% for Q4 2024, -1.0% for Q3 2024, and no change for Q2 2024.

M/I Homes Stock Dynamics

As of the latest updates, shares of M/I Homes were trading at $114.28. The past year has not been rosy for shareholders, as stocks have dipped 20.53%. These trends inevitably lead to a cautious outlook among long-term investors ahead of the earnings report.

Insights from Analysts

Market sentiments can significantly influence stock performance. Currently, there is a consensus rating reflecting a 'Buy' sentiment for M/I Homes, with an average price target set at $140.00. This indicates a potential upside of approximately 22.51%, stirring intrigue among investors.

Comparative Analysis with Competitors

It's also critical to place M/I Homes’ performance in context with its competitors in the housing sector. Tri Pointe Homes, Cavco Industries, and Green Brick Partners serve as important benchmarks. Current ratings suggest:

  • Tri Pointe Homes: Analysts believe it will outperform, with a price target of $43.00 indicating a significant downside risk of 62.37%.
  • Cavco Industries holds a neutral rating with an optimistic price target of $550.00, reflecting a staggering potential upside of 381.27%.
  • Green Brick Partners receives a buy rating with an average target of $71.00, suggesting a 37.87% downside.

Peer Company Metrics

Examining the metrics reveals a contextual landscape for M/I Homes:

CompanyConsensusRevenue GrowthGross ProfitReturn on Equity
M/I HomesBuy-6.75%$252.78M3.74%
Tri Pointe HomesOutperform-21.13%$178.30M1.92%
Cavco IndustriesNeutral21.00%$116.12M3.42%
Green Brick PartnersBuy11.24%$155.78M4.62%

The data indicates that M/I Homes excels in gross profit and return on equity compared to its peers while being positioned in the middle concerning revenue growth.

Understanding M/I Homes and Its Business Model

M/I Homes Inc. engages in residential construction with a dual focus on homebuilding and financial services. Its operations span various geographic regions and cater to diverse buyer segments, including entry-level to luxury homebuyers.

Financial Health Overview

When assessing M/I Homes' market capitalization, it is observed that the company is smaller than many of its competitors. This might affect its growth perception amongst market participants. Recent reports indicate a revenue decline of about 6.75%. Still, M/I Homes maintains a commendable net margin exceeding the industry average, supporting robust profitability.

Debt management is another positive aspect, as evident from its manageable debt-to-equity ratio of 0.33, reflecting prudent financial strategies against the backdrop of a challenging market. The return on assets, rated at 2.44%, showcases effective asset utilization.

Frequently Asked Questions

What is the expected EPS for M/I Homes?

The expected earnings per share (EPS) for M/I Homes is projected at $4.43.

How has M/I Homes performed in previous earnings?

In the past, M/I Homes missed its EPS target by $0.18, yet the share price increased by 1.74% the following day.

What are analysts' opinions on M/I Homes?

The current consensus among analysts indicates a 'Buy' rating with an average price target estimated at $140.00, suggesting potential upside.

How does M/I Homes compare to competitors?

M/I Homes shows strong gross profit and return on equity but has faced challenges in revenue growth compared to competitors.

What does M/I Homes focus on?

M/I Homes specializes in residential construction, providing services to various homebuyer segments, supported by financial services operations.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Wheaton Shines with Record Results in YTD 2026

Updated Category News Views 94

Winds of Change Favor Wheaton Precious Metals Economic landscapes rarely offer serene sailing, except that Wheaton Precious Metals seems to have caught a gust that’s taken them to exhilarating heights. Their third-quarter numbers and the record year-to-date performance stand testament to their foresight and finesse in managing assets in a volatile market. Numbers That...

Continue Reading
UN's AI Toolbox Aims to Keep City Oversight Human

Updated Category News Views 68

Artificial Intelligence: Tool or Tyrant? Ever feel like we're on a runaway train with this AI business in city management? The United Nations seems to think so, and it’s stepping in with a big red STOP sign—or rather, a toolbox. This week, in a grand procession at Barcelona's Smart City Expo, they rolled out the United for Smart Sustainable Cities (U4SSC) Toolbox,...

Continue Reading
LaserAway Opens 241st Clinic, Marks 20-Year Milestone

Updated Category News Views 48

LaserAway's New Chapter in Paramus Out of the glitz of Los Angeles and into the hustle of Paramus, LaserAway's latest clinic isn't just a ribbon-cutting ceremony—it's a milestone in the aesthetic dermatology space. Boasting its 241st location, LaserAway is marking twenty years of relentless expansion without ever closing a single clinic. Now that's a track record that'd...

Continue Reading
Aberlour Elevates U.S. Market with New Whisky Launches

Updated Category News Views 55

Aberlour's Bold U.S. Expansion Aberlour isn't just gently knocking on the U.S. market's door; they're making a hefty entry with a couple of heavy hitters—a 14-Year-Old and a 21-Year-Old single malt Scotch whisky. And trust me when I say, they've got their eyes on being top-shelf material. It seems they're not tiptoeing into the States; they're striding in with...

Continue Reading
Chesapeake Utilities Q3 2026: Growth Meets Strategy

Updated Category News Views 106

Chesapeake Utilities Shows Strong Q3 2026 Growth Chesapeake Utilities Corporation (NYSE: CPK) ain't pulling any punches this quarter. They're showing off some solid numbers, with net income for Q3 hitting $21.6 million and EPS coming in at $0.89. Not just stopping there, these fellas are flexing a year-to-date growth rate of 8.4% on Adjusted EPS. Now, you gotta pay...

Continue Reading
NovoTech Climbs Charts: Chambers USA Spotlight Kudos

Updated Category News Views 91

NovoTech's Moment in the Spotlight Every once in a while, a small fish manages to swim with the sharks and come out shining. NovoTech, a relative newcomer in the swarm of patent law firms, has snagged itself a spot in the inaugural Chambers USA Spotlight 2027 DC Metro Guide. Considering they're playing in the bustling intellectual property scene, this is no small...

Continue Reading
AiNET Prevails in Breach of Contract Jury Verdict

Updated Category News Views 115

AiNET's Legal Triumph Shakes Up the IT Sector Well, talk about a courtroom drama. Greenberg Traurig just snagged a big win for AiNET over in Prince George's County, Maryland, and it's a classic reminder that due diligence isn't just a nice-to-have—it's a must. AiNET found itself in the center of a breach of contract brawl with Tech Finance Co., and guess what? The jury...

Continue Reading
ABCmouse Teams with Netflix for Global Learning Expansion

Updated Category News Views 149

ABCmouse Reinvents Learning in a Digital Age Just when you thought the kids’ education scene couldn’t get any tech-savvier, ABCmouse swoops in with a new game changer. In collaboration with Netflix, the folks at Age of Learning have launched a slick mobile game that’ll keep the kiddies learning in the palm of their hands. Screen time just turned into brain-building...

Continue Reading
VS Pharmtech Enhances Cancer Drug Efficiency, Eyes IPO

Updated Category News Views 25

Revolutionizing Cancer Care, One Dose at a Time Now, here's a twist worth chewing over your morning coffee: VS Pharmtech isn't concocting some newfangled miracle drug but is instead jazzing up the old ones. Their creation, VS-101, isn't just another treatment—it's a radiosensitizer designed to make existing therapies more potent without the toxic baggage. The Science...

Continue Reading
Investor Bidding on Off-Market Homes Surges 35% Higher

Updated Category News Views 36

Investor Frenzy in Off-Market Real Estate Looking at the real estate puzzle today, one might spot an unexpected surge in enthusiasm for off-market residential properties. We've got iFinder Offers, a real estate platform that's made it its business to connect the dots between homeowners and a gaggle of over 325 hungry investors. And according to their magic spreadsheets,...

Continue Reading

Top 5 Most Recently Viewed Articles

Benitec Biopharma Sets Stage for Exciting March Conferences

Updated Category News Views 121

Benitec Biopharma's Upcoming Conference Engagements Benitec Biopharma Inc. (NASDAQ: BNTC), a pioneering biotechnology company focused on gene therapy, is gearing up for a series of impactful conferences this March. These events present an excellent platform for the company's management team to showcase their innovative approaches in developing genetic medicines through...

Continue Reading
Prairie Operating Co. Announces Upcoming Year-End Investor Call

Updated Category News Views 83

Prairie Operating Co. Announces Year-End Update Call Prairie Operating Co. is set to showcase its accomplishments during an upcoming conference call, shedding light on the company’s operations and key milestones achieved in the year 2024. This significant event is scheduled for a Thursday afternoon, providing investors and interested listeners a chance to connect with...

Continue Reading
Analysts Rally Behind Vir Biotechnology: New Price Targets

Updated Category News Views 186

Analysts Get Bullish On Vir Biotechnology In a shake-up that’s rattling stocks, Vir Biotechnology is striding forward after some eye-catching Q4 numbers. The company just reported a loss of 31 cents a share, which is better than the expected 41 cents. Cash flow wasn’t a total disaster, as they brought in $64.07 million in sales—way ahead of the $23.18 million...

Continue Reading
Netcracker Technology Wins 2024 OSS/BSS Excellence Award

Updated Category News Views 46

Netcracker Technology Honored with 2024 OSS/BSS Award Netcracker Technology has been awarded the title of 2024 Asia-Pacific OSS/BSS Company of the Year from Frost & Sullivan. This recognition showcases the company's commitment to delivering exceptional cloud-native solutions tailored for service providers in the region. Leading Cloud-Native Solutions The award emphasizes...

Continue Reading
How a Coffee Meeting Saved Amazon's Future with Costco Insight

Updated Category News Views 394

The Coffee Conversation That Changed Amazon Amazon.com Inc., now valued at an impressive $2 trillion, faced a bleak future back in 2001 following the collapse of the dot-com bubble. The once soaring stock of Amazon had plunged to an all-time low, resulting in a staggering 90% decrease. Critics were quick to announce its impending failure. Jeff Bezos Meets Costco’s Jim...

Continue Reading